Jing Qi
- Molecular Biology top 10%
- Biomedical Engineering top 5%
- Materials Chemistry top 10%
- Biomaterials top 2%
- Immunology top 10%
- Topics
- Nanoplatforms for cancer theranostics (14 papers)Antibiotic Resistance in Bacteria (8 papers)Immune Cell Function and Interaction (8 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Jing Qi
65 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Biology 829
- Biomedical Engineering 819
- Materials Chemistry 452
- Biomaterials 439
- Immunology 354
Countries citing papers authored by Jing Qi
This map shows the geographic impact of Jing Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Qi more than expected).
Fields of papers citing papers by Jing Qi
This network shows the impact of papers produced by Jing Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Qi. The network helps show where Jing Qi may publish in the future.
Co-authorship network of co-authors of Jing Qi
This figure shows the co-authorship network connecting the top 25 collaborators of Jing Qi. A scholar is included among the top collaborators of Jing Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Qi. Jing Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 27 | |
| 3 | 6 | |
| 4 | 16 | |
| 5 | 23 | |
| 6 | 122 | |
| 7 | 161 | |
| 8 | ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injurybreakdown → | 266 |
| 9 | 26 | |
| 10 | 43 | |
| 11 | 53 | |
| 12 | 9 | |
| 13 | 56 | |
| 14 | 58 | |
| 15 | 77 | |
| 16 | 28 | |
| 17 | 102 | |
| 18 | 6 | |
| 19 | 4 | |
| 20 | 50 |
About Jing Qi
Jing Qi is a scholar working on Molecular Medicine, Immunology and Allergy and Immunology, having authored 66 papers that have together received 2.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), Antibiotic Resistance in Bacteria (8 papers) and Immune Cell Function and Interaction (8 papers). The work is most often cited by research in Molecular Medicine (257 citations), Biomaterials (439 citations) and Nephrology (213 citations). Jing Qi has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Yongzhong Du, Gaofeng Shu, Xiaoling Xu, Xiaoying Ying, Feiyang Jin, Di Liu, Jiansong Ji, Saiping Jiang, Xu-Qi Kang and Hui Yu. Their work appears in journals such as Chemical Reviews, Chemical Society Reviews and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.